Rapid Enhancement of Glutamatergic Neurotransmission in Bipolar Depression Following Treatment with Riluzole
- 2 December 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neuropsychopharmacology
- Vol. 35 (3), 834-846
- https://doi.org/10.1038/npp.2009.191
Abstract
Glutamatergic abnormalities may underlie bipolar disorder (BD). The glutamate-modulating drug riluzole may be efficacious in bipolar depression, but few in vivo studies have examined its effect on glutamatergic neurotransmission. We conducted an exploratory study of the effect of riluzole on brain glutamine/glutamate (Gln/Glu) ratios and levels of N-acetylaspartate (NAA). We administered open-label riluzole 100–200 mg daily for 6 weeks to 14 patients with bipolar depression and obtained imaging data from 8-cm3 voxels in the anterior cingulate cortex (ACC) and parieto-occipital cortex (POC) at baseline, day 2, and week 6 of treatment, using two-dimensional J-resolved proton magnetic resonance spectroscopy at 4 T. Imaging data were analyzed using the spectral-fitting package, LCModel; statistical analysis used random effects mixed models. Riluzole significantly reduced Hamilton Depression Rating Scale (HAM-D) scores (d=3.4; pd=1.2; p=0.023). NAA levels increased significantly from baseline to week 6 (d=1.2; p=0.035). Reduction in HAM-D scores was positively associated with increases in NAA from baseline to week 6 in the ACC (d=1.4; p=0.053), but was negatively associated in the POC (d=9.6; p<0.001). Riluzole seems to rapidly increase Gln/Glu ratios—suggesting increased glutamate–glutamine cycling, which may subsequently enhance neuronal plasticity and reduce depressive symptoms. Further investigation of the Gln/Glu ratio as a possible early biomarker of response to glutamate-modulating therapies is warranted.This publication has 63 references indexed in Scilit:
- Targeting glial physiology and glutamate cycling in the treatment of depressionBiochemical Pharmacology, 2009
- Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: an in vivo localized 1 H MRS studyNMR in Biomedicine, 2009
- Ampakines cause sustained increases in brain-derived neurotrophic factor signaling at excitatory synapses without changes in AMPA receptor subunit expressionNeuroscience, 2009
- Abnormal Glutamatergic Neurotransmission and Neuronal-Glial Interactions in Acute ManiaBiological Psychiatry, 2008
- Hippocampal N-Acetylaspartate Concentration and Response to Riluzole in Generalized Anxiety DisorderBiological Psychiatry, 2008
- Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1European Journal of Pharmacology, 2008
- Quantitative proton spectroscopic imaging of the neurochemical profile in rat brain with microliter resolution at ultra‐short echo timesMagnetic Resonance in Medicine, 2007
- Preliminary Evidence of Riluzole Efficacy in Antidepressant-Treated Patients with Residual Depressive SymptomsBiological Psychiatry, 2007
- N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiologyProgress in Neurobiology, 2007
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993